Not only are there drugs targeting each receptor molecule but the monoclonal antibody tocilizumab to ACE2 is also very effective and inhibits viral infection of the organoid even at 100-fold dilution (Song et al., 2020). Here, ACE2 is linked to viral infectious disease.